97 related articles for article (PubMed ID: 4180706)
21. [Heterogenicity of antinuclear immunoglobulins: simultaneous demonstration of classes and types of nuclear fluorescence with the "2-layer" and "3-layer" immunofluorescence test].
Zitnan D; Cebecauer L; Saradinová M; Misurová V
Fysiatr Revmatol Vestn; 1969 Apr; 47(2):54-62. PubMed ID: 4181078
[No Abstract] [Full Text] [Related]
22. Cyclophosphamide treatment of mouse systemic lupus erythematosus.
Horowitz RE; Dubois EL; Weiner J; Strain L
Lab Invest; 1969 Sep; 21(3):199-206. PubMed ID: 4185855
[No Abstract] [Full Text] [Related]
23. [Protein-analytical studies on the serum and urine of patients with visceral lupus erythematosus].
Beenken O; Häntzschel H; Birkenmeier G; Pietruschka WD; Otto W
Z Gesamte Inn Med; 1976 Mar; 31(6):180-2. PubMed ID: 60006
[TBL] [Abstract][Full Text] [Related]
24. Lymphocytopenia in lupus erythematosus: close in vivo association to autoantibodies targeting nuclear antigens.
Wenzel J; Gerdsen R; Uerlich M; Bauer R; Tueting T; Bieber T
Br J Dermatol; 2004 May; 150(5):994-8. PubMed ID: 15149515
[TBL] [Abstract][Full Text] [Related]
25. [Clinical significance of combined detection of 7 kinds of antinuclear antibodies with immunoblotting techniques].
Qing Z
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):373-4. PubMed ID: 9868105
[No Abstract] [Full Text] [Related]
26. Lupoid features in a case of leprosy.
Bonomo L; Dammacco F; Tursi A; Barbieri G
Int J Lepr Other Mycobact Dis; 1967; 35(1):65-71. PubMed ID: 4164256
[No Abstract] [Full Text] [Related]
27. Autoantibodies to the 20-kDa ribosomal proteins: identification, characterization, and new aspects on prevalence in systemic Lupus erythematosus.
Anderson CJ; Neas BR; Uchiumi T; Stafford HA
Clin Immunol; 2001 Feb; 98(2):249-57. PubMed ID: 11161982
[TBL] [Abstract][Full Text] [Related]
28. [Anti-U1RNP antibodies and lupus nephritis].
Ilić T; Curić S; Vodopivec S; Mitić I; Durdević-Mirković T; Sakac V; Lenert P
Med Pregl; 2000; 53(11-12):589-94. PubMed ID: 11320745
[TBL] [Abstract][Full Text] [Related]
29. [Analysis of antinuclear antibodies by fluorescent antibody technic using tissue culture cells].
Onodera S; Shibata A; Miura A; Suzuki A; Sakamoto S
Saishin Igaku; 1969 May; 24(5):1113-7. PubMed ID: 4185953
[No Abstract] [Full Text] [Related]
30. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
[TBL] [Abstract][Full Text] [Related]
31. Antinuclear antibodies directed against proliferating cell nuclear antigen are not specifically associated with systemic lupus erythematosus.
Vermeersch P; De Beeck KO; Lauwerys BR; Van den Bergh K; Develter M; Mariën G; Houssiau FA; Bossuyt X
Ann Rheum Dis; 2009 Nov; 68(11):1791-3. PubMed ID: 19822716
[No Abstract] [Full Text] [Related]
32. Antinuclear antibody-negative systemic lupus erythematosus: loss in body fluids.
Persellin RH; Takeuchi A
J Rheumatol; 1980; 7(4):547-50. PubMed ID: 6999153
[TBL] [Abstract][Full Text] [Related]
33. Anti-RO anti-LA anti-RNP antibodies and eletrocardiogram's PR interval in adult patients with systemic lupus erythematosus.
Costa M; Gameiro Silva MB; Silva JA; Skare TL
Acta Reumatol Port; 2008; 33(2):173-6. PubMed ID: 18604183
[TBL] [Abstract][Full Text] [Related]
34. [Fluctuation of serum complement activities in systemic lupus erythematosus and its clinical significance].
Okuda M
Naika; 1970 Feb; 25(2):353-8. PubMed ID: 5309587
[No Abstract] [Full Text] [Related]
35. ANTINUCLEAR FACTORS IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS.
BARNETT EV; NORTH AF; CONDEMI JJ; JACOX RF; VAUGHAN JH
Ann Intern Med; 1965 Jul; 63():100-8. PubMed ID: 14305956
[No Abstract] [Full Text] [Related]
36. [Nucleic acids and reactive glycoproteins of the blood in systemic lupus erythematosus].
Volkova ZI
Ter Arkh; 1979; 51(8):103-9. PubMed ID: 92065
[No Abstract] [Full Text] [Related]
37. The immunofluorescent "band" test for lupus erythematosus. I. Morphologic variations of the band of localized immunoglobulins at the dermal-epidermal junction in lupus erythematosus.
Burnham TK; Fine G
Arch Dermatol; 1969 Apr; 99(4):413-20. PubMed ID: 4181409
[No Abstract] [Full Text] [Related]
38. Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus.
Suzuki N; Harada T; Mizushima Y; Sakane T
J Immunol; 1993 Jul; 151(2):1128-36. PubMed ID: 8335894
[TBL] [Abstract][Full Text] [Related]
39. [Anti-DNA antibodies in systemic lupus erythematosus (author's transl)].
Clotet B; Ruibal A; Pigrau C; Murcia C; Pahissa A; Lience E
Med Clin (Barc); 1982 Feb; 78(4):128-131. PubMed ID: 6978438
[No Abstract] [Full Text] [Related]
40. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
Husebye ES; Sthoeger ZM; Dayan M; Zinger H; Elbirt D; Levite M; Mozes E
Ann Rheum Dis; 2005 Aug; 64(8):1210-3. PubMed ID: 15708887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
